Injunctive Relief Reformulation Testing and Warnings Sample Clauses

The "Injunctive Relief, Reformulation, Testing and Warnings" clause primarily allows a party to seek court-ordered actions to prevent or address harm related to a product or service, such as requiring changes to its formulation, additional testing, or enhanced warnings. In practice, this clause may be invoked if a product is found to pose safety risks, enabling a party to request that the manufacturer reformulate the product, conduct further safety tests, or update warning labels to better inform consumers. Its core function is to provide a legal mechanism for proactively addressing and mitigating risks, thereby protecting users and reducing potential liability.
Injunctive Relief Reformulation Testing and Warnings. In consideration of the following covenants of SEA SNACK, and the other conditions contained in this Agreement, PHSA releases SEA SNACK as set forth in Section 6 below. For the purposes of this Settlement agreement, the term “Effective Date” shall mean September 24, 2021. 3.1 Beginning on the Effective Date, SEA SNACK shall not manufacture for sale in the State of California, “distribute into the State of California,” or directly sell in the State of California, any Covered Product which expose a person to more than 0.5 micrograms of Lead based on the recommended serving size on the Covered Product’s label, unless each such unit of the Covered Product bears a warning meeting the warning requirements under Section 3.2. Furthermore, beginning on the Effective Date, SEA SNACK shall not manufacture for sale in the State of California, “distribute into the State of California,” or directly sell in the State of California, any Covered Product which expose a person to more than 4.1 micrograms of Cadmium based on the recommended serving size on the Covered Product’s label, unless each such unit of the Covered Product bears a warning meeting the warning requirements under Section 3.2. 3.1.1 As used in this Settlement Agreement and Release, the term “Distribute into the State of California” shall mean to directly ship a Covered Product into California for sale in California or to sell a Covered Product to a distributor that SEA SNACK knows will sell the covered Product in California. 3.1.2 For the Purpose of this Agreement, the amount of Lead or Cadmium a person is exposed to form the Covered Product shall be calculated using the following formula: micrograms of Lead or Cadmium per gram of product, multiplied by grams of product per serving of the product (using the largest serving size appearing on the product label), multiplied by servings of the product per day (using the largest number of servings in recommended dosage appearing on the product label), which equals micrograms of Lead or Cadmium exposure per day.
View Source
Injunctive Relief Reformulation Testing and Warnings. In consideration of the following covenants of PGI, and the other conditions contained in this Agreement, CTWG releases PGI as set forth in Section 6 below: 3.1 Beginning on the Effective Date, PGI shall not manufacture for sale in the State of California, “[d]istribute into the State of California,” or directly sell in the State of California, any Covered Product which expose a person to more than 0.5 micrograms of lead based the 30-day average consumption of 4.29 grams per day for mussels (as determined in the National Health and Examination Survey (“NHANES”) study published by Nature America, Inc. in the Journal of Exposure Science and Environmental Epidemiology (2013), p.128-136 (Table 7) (referred to as the “NHANES Study”), or any NHANES mussels consumption published consumption study for mussels conducted after the NHANES Study; unless each such unit of the Covered Product bears a warning meeting the warning requirements under Section 3.2. 3.1.1 As used in this Settlement Agreement and Release, the term “Distribute into the State of California” shall mean to directly ship a Covered Product into California for sale in California or to sell a Covered Product to a distributor that PGI knows will sell the Covered Product in California. 3.1.2 For the purposes of this Agreement, the amount of lead a person is exposed to from the Covered Product shall be calculated using the following formula: micrograms of lead per gram of product, multiplied by grams of product per day consumed (using the value of 4.29 grams per day per the NHANES Study or otherwise pursuant to Section 3.1 above), which equals micrograms of lead exposure per day.
View Source
Injunctive Relief Reformulation Testing and Warnings 
View SourceView Similar (5)

Related to Injunctive Relief Reformulation Testing and Warnings

  • Evaluation, Testing, and Monitoring 1. The System Agency may review, test, evaluate and monitor Grantee’s Products and services, as well as associated documentation and technical support for compliance with the Accessibility Standards. Review, testing, evaluation and monitoring may be conducted before and after the award of a contract. Testing and monitoring may include user acceptance testing. Neither the review, testing (including acceptance testing), evaluation or monitoring of any Product or service, nor the absence of review, testing, evaluation or monitoring, will result in a waiver of the State’s right to contest the Grantee’s assertion of compliance with the Accessibility Standards. 2. Grantee agrees to cooperate fully and provide the System Agency and its representatives timely access to Products, records, and other items and information needed to conduct such review, evaluation, testing, and monitoring.

  • Procurement Related Complaints and Administrative Review 49.1 The procedures for making a Procurement-related Complaint are as specified in the TDS. 49.2 A request for administrative review shall be made in the form provided under contract forms.

  • Money Market Fund Compliance Testing and Reporting Services Subject to the authorization and direction of the Trust and, in each case where appropriate, the review and comment by the Trust’s independent accountants and legal counsel, and in accordance with procedures that may be established from time to time between the Trust and the Administrator, the Administrator will:

  • DRUG AND ALCOHOL TESTING Employees may be tested for drugs and/or alcohol pursuant to the provisions of the Employer's Drug and Alcohol Testing Policy which is attached hereto and made a part of this Agreement as if more fully set forth herein.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.